ArticleEuropean journal of case reports in internal medicine2025

When Skin Reactions Interrupt Bone Therapy: Severe Cutaneous Adverse Reaction to Romosozumab Leading to Treatment Discontinuation.

Luis Antonio Rodriguez Arrieta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.